These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11249735)

  • 1. Chemotherapy: friend or foe to cancer vaccines?
    Emens LA; Machiels JP; Reilly RT; Jaffee EM
    Curr Opin Mol Ther; 2001 Feb; 3(1):77-84. PubMed ID: 11249735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Augmentation of antitumor immunity in cancer chemotherapy].
    Hosokawa M; Kobayashi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
    Hodge JW; Ardiani A; Farsaci B; Kwilas AR; Gameiro SR
    Semin Oncol; 2012 Jun; 39(3):323-39. PubMed ID: 22595055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of anticancer drugs and immunotherapy.
    Mitchell MS
    Cancer Immunol Immunother; 2003 Nov; 52(11):686-92. PubMed ID: 12942200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On combining antineoplastic drugs with tumor vaccines.
    Terando A; Mulé JJ
    Cancer Immunol Immunother; 2003 Nov; 52(11):680-5. PubMed ID: 12955481
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined modality immunotherapy and chemotherapy: a new perspective.
    Ramakrishnan R; Antonia S; Gabrilovich DI
    Cancer Immunol Immunother; 2008 Oct; 57(10):1523-9. PubMed ID: 18488219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor. Egress of CSF during surgery: a thin line separating transition from a friend to a foe.
    Munakomi S
    J Neurosurg; 2019 Jul; 131(1):331-332. PubMed ID: 30497183
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
    Mlecnik B; Torigoe T; Bindea G; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Hirohashi Y; Furuhata T; Takemasa I; Patel P; Vora H; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Yoshino T; Taniguchi H; Bifulco C; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson E; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Marliot F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; Van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Marincola FM; Ascierto PA; Fox BA; Pagès F; Kawakami Y; Galon J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges.
    Uchimiak K; Badowska-Kozakiewicz AM; Sobiborowicz-Sadowska A; Deptała A
    Clin Med Insights Oncol; 2022; 16():11795549221099869. PubMed ID: 35721387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of Immunocompromised Cats.
    Hartmann K; Möstl K; Lloret A; Thiry E; Addie DD; Belák S; Boucraut-Baralon C; Egberink H; Frymus T; Hofmann-Lehmann R; Lutz H; Marsilio F; Pennisi MG; Tasker S; Truyen U; Hosie MJ
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
    Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
    J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiating cancer vaccine efficacy in liver cancer.
    Tagliamonte M; Petrizzo A; Mauriello A; Tornesello ML; Buonaguro FM; Buonaguro L
    Oncoimmunology; 2018; 7(10):e1488564. PubMed ID: 30288355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?
    Quirk K; Ganapathy-Kanniappan S
    Front Pharmacol; 2017; 8():732. PubMed ID: 29089892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.
    Kuczma M; Ding ZC; Zhou G
    Crit Rev Immunol; 2016; 36(2):179-191. PubMed ID: 27910767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
    Emens LA; Middleton G
    Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.
    Alistar A; Chou JW; Nagalla S; Black MA; D'Agostino R; Miller LD
    Genome Med; 2014; 6(10):80. PubMed ID: 25419236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to sipuleucel-T in prostate cancer.
    Thara E; Dorff TB; Averia-Suboc M; Luther M; Reed ME; Pinski JK; Quinn DI
    Cancers (Basel); 2012 Apr; 4(2):420-41. PubMed ID: 24213318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic tumor cell vaccines: the promise and limitations in clinical trials.
    Srivatsan S; Patel JM; Bozeman EN; Imasuen IE; He S; Daniels D; Selvaraj P
    Hum Vaccin Immunother; 2014; 10(1):52-63. PubMed ID: 24064957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.
    Schueneman AJ; Sugar EA; Uram J; Bigelow E; Herman JM; Edil BH; Jaffee EM; Zheng L; Laheru DA
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S725-30. PubMed ID: 24046118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoimmunotherapy: reengineering tumor immunity.
    Chen G; Emens LA
    Cancer Immunol Immunother; 2013 Feb; 62(2):203-16. PubMed ID: 23389507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.